Finance

Japanese therapeutics company raises $11.3 million in series C financing

Published in Cancer Weekly, January 18th, 2005

Y's Therapeutics Co., Ltd., a privately held biopharmaceutical company, announced it has raised a total of 1.2 billion yen (U.S. $11.3 million) through a series C financing from new and existing investors.

Key investors in this financing included Zenkoku Hosho Co., Ltd., Softbank Investment Corp. (through its managed investment fund) and Kyorin Pharmaceutical Co., Ltd.

Y's Therapeutics has 5 projects in its portfolio. YSIL6 is a small molecule drug development project for treatment of rheumatoid arthritis and other inflammatory disorders. The molecule's modes of action include inhibition of TNF-a and IL-6 production in T-cells and macrophages and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-01-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry